Patent US4820261A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4820261A Expired / Lapsed US ⏱️ 0.0 years remaining

Device for the removal of therapeutic substances locally applied for use against solid tumors

Assignee: Pharma Biotechnologie Hannover GmbH
•
Filing: 1987-08-19
•
Granted: 1989-04-11
•
Expires: 2007-08-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A device for the removal of active substances locally applied against solid tumors consists of a catheter (1) to be positioned distally to the tumor for the collection of blood coming from the tumor, a pump (2) anda catheter (3) connected thereto and returning the blood into the body. The device is characterized in that between the two catheters (1, 3) there is present at least one container (4) capable of allowing blood to pass therethrough and containing immobilized antibodies against the applied active substance.

Inventors

  • 👤 Hans-Joachim Schmoll
  • 👤 Ekkehard Schmoll
  • 👤 Edmund R. Lax

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:04
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/10; A61M25/1011; A61M1/00; A61M1/36; A61M1/3615; A61M1/3679; A61M25/01; A61M25/0105; A61M25/0108

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 170 words
A device for removing a substance from the human circulatory system comprising (a) a first catheter having one end positionable in a blood vessel distally from a tumor for removing blood from the vessel, (b) a second catheter having one end positionable in the blood vessel for returning blood to the vessel and forming with the first catheter a double catheter along at least part of their length such that the one end of the first catheter is joined to the second catheter at a distance from the one end of the second catheter, (c) a pump connected to the first and second catheters, (d) at least one container holding immobilized antibodies to the substance and connected to the first and second catheters such that blood passes from the first catheter to the second catheter through the container, and (e) an inflatable balloon for blocking the blood vessel when inflated and located on the second catheter between the end of the first catheter and the end of the second catheter.
Claim 2
Independent Claim 170 words
A device for removing a substance from the human circulatory system comprising (a) a first catheter having one end positionable in a blood vessel distally from a tumor for removing blood from the vessel, (b) a second catheter having one end positionable in the blood vessel for returning blood to the vessel and forming with the first catheter a double catheter along at least part of their length such that the one end of the first catheter is joined to the second catheter at a distance from the one end of the second catheter, (c) a pump connected to the first and second catheters, (d) at least one container holding immobilized antibodies to the substance and connected to the first and second catheters such that blood passes from the first catheter to the second catheter through the container, and (e) an inflatable balloon for blocking the blood vessel when inflated and located on the second catheter between the end of the first catheter and the end of the second catheter.
Claim 3
Dependent Claim 21 words
A device according to claim 1 further comprising a second balloon located on the double catheter for blocking the blood vessel.
Claim 4
Dependent Claim 27 words
Device according to claim 1, characterized in that the immobilized antibody present in the container is directed against active substances of blood cells and/or blood cell precursors.
Claim 5
Dependent Claim 22 words
Device according to claim 1, characterized in that the immobilized antibody present in the container is active against lymphokines, monokines and/or cytokines.
Claim 6
Dependent Claim 31 words
Device according to claims 1, characterized in that the immobilized antibody present in the container is directed against interferons, interleukins, colony stimulating factors, tumour necrosis factor, lymphotoxin and/or transforming growth factors.

References Cited (Backward Citations)

US4573966A Cited
DE3214397A1 Cited
US4605394A Cited
US4614513A Cited
DE3523616A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-04-10 1992-10-10 1993-04-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-04-10 1996-10-10 1997-04-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-04-10 2000-10-10 2001-04-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag